Financial Architects (New Jersey)’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Financial Architects (New Jersey)’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-500	Closed	-$32K	–	1492
2016 Q2	$32K	Sell	500 -510	-50%	-$32.1K	0.01%	655
2016 Q1	$61K	Buy	+1,010	New	+$61.8K	0.02%	362
2015 Q3	–	Sell	-691	Closed	-$54K	–	719
2015 Q2	$54K	Buy	+691	New	+$53.8K	0.02%	422
2015 Q1	–	Sell	-601	Closed	-$40K	–	1009
2014 Q4	$40K	Buy	601 +151	+34%	+$10.1K	0.02%	383
2014 Q3	$29K	Buy	450 +20	+5%	+$1.24K	0.01%	398
2014 Q2	$26K	Buy	+430	New	+$24.9K	0.01%	445

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Financial Architects (New Jersey)'s PJP Position: Q3 2016 in Review

Financial Architects (New Jersey) sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2016, closing a stake of 500 shares — an estimated $32K sold.

Financial Architects (New Jersey) first reported a position in PJP in Q2 2014 and held it in 6 quarters. The position peaked at $61K in Q1 2016. 96 funds tracked by Wall St. Rank hold PJP as of Q3 2016.

Financial Architects (New Jersey) reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2016 after selling out during the quarter.
Financial Architects (New Jersey) sold 500 Invesco Pharmaceuticals ETF shares in Q3 2016, an estimated $32K.
Financial Architects (New Jersey) first reported a position in Invesco Pharmaceuticals ETF in Q2 2014 and held it in 6 quarters.
Financial Architects (New Jersey)'s Invesco Pharmaceuticals ETF position peaked at $61K in Q1 2016.
96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2016.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2016, filed 28 Oct 2016.